Business
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
OSR Holdings, Inc. (NASDAQ: OSRH) ("OSR Holdings"), a global healthcare holding company, today announced that the shareholders of Woori IO Co., Ltd. ("Woori IO"), a leading Korean medical device innovator in noninvasive glucose monitoring technology, approved a share exchange at an Extraordinary General Meeting ("EGM") held at Woori IO's headquarters in Jeonju, Korea. The approved share exchange will result in Woori IO becoming a wholly-owned subsidiary of OSR Holdings Co., Ltd. ("OSRK"), the Ko
About this update from Samsung Electronics Co., Ltd.
[{"type":"text","content":"Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university","length":170,"tagName":"p","attribs":{}},{"type":"text","content":"BELLEVUE, Wash., Dec. 19, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) ("OSR Holdings"), a global healthcare holding company, today announced that the shareholders of Woori IO Co., Ltd. ("Woori IO"), a leading Korean medical device innovator in noninvasive glucose monitoring technology, approved a share exchange at an Extraordinary General Meeting ("EGM") held at Woori IO's headquarters in Jeonju, Korea. The approved share exchange will result in Woori IO becoming a wholly-owned subsidiary of OSR Holdings Co., Ltd. ("OSRK"), the Korean intermediate holding company of OSR Holdings, Inc.","length":651,"tagName":"p"},{"type":"text","content":"Upon completion of the share exchange, Woori IO will become a wholly-owned subsidiary of OSRK, marking the final step in a sequence of corporate actions designed to integrate Woori IO fully into the OSR Group ecosystem.","length":219,"tagName":"p"},{"type":"text","content":"Woori IO is currently collaborating with Samsung Electronics on a Proof-of-Concept ("PoC") study in South Korea aimed at achieving Korean regulatory approval for its breakthrough noninvasive blood glucose monitoring platform.","length":235,"tagName":"p"},{"type":"text","content":"With the corporate combination now finalized, Woori IO also plans to initiate U.S. market development activities, supported by an invitation from a prestigious research university to collaborate on a U.S. FDA clinical trial for Woori IO's technology. This collaboration is expected to serve as a foundation for advancing Woori IO's regulatory and commercial strategy in the United States.","length":396,"tagName":"p"},{"type":"text","content":""Integrating Woori IO into OSR Group strengthens the foundation for global expansion," said Peter Hwang, CEO of OSR Holdings. "We look forward to supporting Woori IO as it advances its regulatory pathways in Korea and begins its U.S. clinical initiatives. Their breakthrough noninvasive glucose monitoring technology represents a major step toward improving metabolic health worldwide."...